[NATAP] IAS Rome: Comorbidities

[Guest guest]

Subject: [NATAP] IAS Rome: ComorbiditiesIAS Rome: ComorbiditiesIAS: Risk of Osteoporotic Fractures Associated with Cumulative Exposure to Tenofovir and Other Antiretroviral Agents - written by Mark Mascolini - (07/18/11)IAS: Risk of Osteoporotic Fractures Associated with Cumulative Exposure to Tenofovir and Other Antiretroviral Agents - (07/18/11)Intl Wrkshp Advrse Reactions & Comorbids HIV: Bone

Mineral Density (BMD) Analysis in Antiretroviral (ART)-Naïve Subjects Taking Lopinavir/ritonavir (LPV/r) Combined with Raltegravir (RAL) or Tenofovir/Emtricitabine (TDF/FTC) for 96 weeks in the PROGRESS Study - (07/17/11)IAS: Antiretroviral

Therapy Lowers HIV Transmission Risk in HIV+/HIV- Couples: "96% reduction in HIV transmission risk to an HIV-negative partner..... definitive proof of the concept that antiretroviral therapy lowers the risk HIV transmission" - written by Mark Mascolini - (07/18/11)IAS: Short-Term ART After Early Infection Does Not Delay AIDS or Death - written by Mark Mascolini - (07/26/11)Intl Wrkshp Advrse Reactions & Comorbids HIV: Metabolic

Risk Factors in Responders to Tesamorelin, a Growth Hormone-Releasing Factor (GRF) Analogue, in HIV-Infected Patients with Excess Abdominal Fat - (07/17/11)IAS: Biomarkers Predict Hepatic Flares and Death in Hepatitis-Coinfected People Starting ART - written by Mark Mascolini - (07/26/11)IAS: Progressive Histological Liver Improvement After SVR in HCV/HIV Coinfected Patients Using Transient Elastography (Fibroscan) - (07/25/11)IAS: Cognitive

Impairment Persists: Prevalence and risk factors for HIV associated neurococognitive disorders (HAND), 1996 to 2010: results from an observational cohort - (07/25/11)IAS: Slow Drop in HIV Neurocognitive Disorder in Italian HIV Cohort: 'cognitive impairment persists in HIV-positive people.....' - written by Mark Mascolini - (07/19/11)IAS: Doubled Rate of Nonmelanoma Skin Cancer With HIV in California Comparison - written by Mark Mascolini - (07/24/11)IAS: More Than 25% in HIV-Positive SUN Study Cohort Have Insulin Resistance - written by Mark Mascolini - (07/22/11)IAS: TDF/FTC PrEP Durable in MSM, But MSM and Transgender Responses Differ - written by Mark Mascolini - (07/22/11)IAS: Antiretroviral drugs and incidence of chronic kidney disease, ANRS CO3 Aquitaine Cohort, France, 2004-2008 - (07/23/11)IAS: Safety

Profile of Dolutegravir (DTG, S/GSK1349572), a Next Generation Integrase Inhibitor (INI) in Combination Therapy in Antiretroviral (ART)-naïve and ART-experienced

Adults from Phase 2b Studies - (07/23/11)Sexual Transmission of Hepatitis C Virus Among HIV-Infected Men Who Have Sex with Men --- New York City, 2005--2010 - (07/22/11)IAS: Frailty Rate in HIV+ mid-50 Women Matches Rate in 70-Year-Olds Without HIV - written by Mark Mascolini - (07/20/11)IAS: Heart Disease Signal and Low Femoral Density Linked in People With HIV - written by Mark Mascolini - (07/20/11)IAS: Interaction

of Vascular and Bone Disease in HIV Infected Patients: Coronary Artery Calcification is associated with femoral but not lumbar spine mineral density - (07/19/11)IAS: Elvitegravir Not Inferior to Raltegravir in Treatment-Experienced: Phase 3 - written by Mark Mascolini - (07/20/11)IAS: Pooled

Week 96 efficacy, resistance and safety results from the double-blind, randomised, Phase III trials comparing rilpivirine (RPV, TMC278) versus efavirenz (EFV) in treatment-naïve, HIV-1-infected adults - (07/20/11)6th IAS Conference on HIV Pathogenesis

Treatment and Prevention

July 17-20, 2011, Rome